Trigger Finger Treatment
- Conditions
- Stenosing TenosynovitisTrigger FingerTrigger Digit
- Registration Number
- NCT03847935
- Lead Sponsor
- University of Massachusetts, Lowell
- Brief Summary
Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness and/or snapping during movement. This observational study compared all of the possible treatments and combinations of treatments for trigger finger at the A1 pulley, including surgery, cortisone injections and hand therapy.
- Detailed Description
Trigger finger is a common disorder of the hand which causes pain at the A1 pulley, inflammation, stiffness or snapping during movement. This can be very debilitating. Current treatment includes local steroid injection, oral NSAIDS, resting orthoses, physical or occupational therapy and surgical intervention. The aim of this prospective study with an observational design was to determine the outcome between surgical, hand therapy rehabilitation, and corticosteroid injection interventions for trigger finger. There were 6 treatment groups: surgery, corticosteroid injection, 1 visit of hand therapy for orthosis fabrication and therapeutic exercise, hand therapy in combination with cortisone injection, Modality hand therapy alone (ongoing visits) or with corticosteroid injections.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 86
- trigger finger in digit 2-5
- if prior treatment for trigger finger, or Trigger thumb
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Edema 6 months day 1, 6 months Baseline to 6 months weeks Circumferential measurement in centimeters of the proximal phalanx
Change in Range of motion 3 months 1 day, 3 months Baseline to 3 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
Change in Severity or Grade of triggering 6 weeks 1 day, 6 weeks Baseline to 6 weeks Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Change in Edema 6 weeks day 1, 6 weeks Baseline to 6 weeks Circumferential measurement in centimeters of the proximal phalanx
Change in Pain on a likert scale 6 months 1 day, 6 months Baseline to 6 months pain on a 0-10 scale
Change in Range of motion 6 weeks 1 day, 6 weeks Baseline to 6 weeks flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
Change in Functional use using Quick DASH 6 weeks Day 1, 6 weeks Change from baseline to 6 weeks Quick DASH
Change in Edema 3 months day 1, 3 months Baseline to 3 months weeks Circumferential measurement in centimeters of the proximal phalanx
Change in Pain on a likert scale 6 weeks 1 day, 6 weeks Baseline to 6 weeks pain on a 0-10 scale
Change in Severity or Grade of triggering 3 months 1 day, 3 months Baseline to 3 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Change in Functional use using Quick DASH 3 months Day 1, 3 months Change from baseline to 3 months Quick DASH
Change in Functional use using Quick DASH 6 months Day 1, 6 months Change from baseline to 6 months Quick DASH
Change in Pain on a likert scale 3 months 1 day, 3 months Baseline to 3 months pain on a 0-10 scale
Change in Severity or Grade of triggering 6 months 1 day, 6 months Baseline to 6 months Using the scale by Patel and Bassini to measure the amount of triggering 1=normal joint, 6=locked in flexion
Change in Range of motion 6 months 1 day, 6 months Baseline to 6 months flexion and extension range of motion at metacarpophalangeal (MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP) using a finger goniometer.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.